Mitsubishi UFJ Trust & Banking Corp decreased its holdings in shares of Core Laboratories N.V. (NYSE:CLB) by 1.5% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 83,350 shares of the oil and gas company’s stock after selling 1,275 shares during the period. Mitsubishi UFJ Trust & Banking Corp owned about 0.19% of Core Laboratories N.V. worth $8,441,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also made changes to their positions in CLB. Parallel Advisors LLC lifted its holdings in Core Laboratories N.V. by 33.4% in the 1st quarter. Parallel Advisors LLC now owns 891 shares of the oil and gas company’s stock valued at $101,000 after purchasing an additional 223 shares in the last quarter. Quantbot Technologies LP purchased a new position in Core Laboratories N.V. in the 1st quarter valued at $106,000. FNY Managed Accounts LLC purchased a new position in Core Laboratories N.V. in the 1st quarter valued at $123,000. Shine Investment Advisory Services Inc. purchased a new position in Core Laboratories N.V. in the 2nd quarter valued at $134,000. Finally, First Bank & Trust lifted its holdings in Core Laboratories N.V. by 5.8% in the 2nd quarter. First Bank & Trust now owns 1,493 shares of the oil and gas company’s stock valued at $152,000 after purchasing an additional 82 shares in the last quarter.

A number of research analysts have weighed in on the company. BidaskClub upgraded Core Laboratories N.V. from a “sell” rating to a “hold” rating in a report on Tuesday, June 13th. Royal Bank Of Canada set a $145.00 price objective on Core Laboratories N.V. and gave the company a “buy” rating in a report on Saturday, June 17th. Zacks Investment Research upgraded Core Laboratories N.V. from a “hold” rating to a “buy” rating and set a $116.00 price objective on the stock in a report on Monday, June 12th. Morgan Stanley restated an “overweight” rating and issued a $130.00 price objective (down previously from $150.00) on shares of Core Laboratories N.V. in a report on Wednesday, June 21st. Finally, ValuEngine lowered Core Laboratories N.V. from a “hold” rating to a “sell” rating in a report on Tuesday, June 6th. Four research analysts have rated the stock with a sell rating, eight have issued a hold rating and five have assigned a buy rating to the company. Core Laboratories N.V. presently has a consensus rating of “Hold” and an average price target of $113.58.

Shares of Core Laboratories N.V. (NYSE:CLB) opened at 91.18 on Friday. Core Laboratories N.V. has a 52 week low of $86.55 and a 52 week high of $125.83. The firm has a 50 day moving average price of $94.24 and a 200-day moving average price of $105.02. The firm has a market capitalization of $4.02 billion, a P/E ratio of 55.94 and a beta of 1.60.

Core Laboratories N.V. (NYSE:CLB) last issued its quarterly earnings data on Monday, July 24th. The oil and gas company reported $0.52 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.51 by $0.01. Core Laboratories N.V. had a return on equity of 49.29% and a net margin of 11.80%. The business had revenue of $163.90 million for the quarter, compared to the consensus estimate of $168.23 million. During the same period in the prior year, the business earned $0.35 earnings per share. The business’s revenue was up 10.7% on a year-over-year basis. Equities research analysts predict that Core Laboratories N.V. will post $2.04 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Monday, August 14th. Stockholders of record on Monday, July 17th were given a $0.55 dividend. The ex-dividend date was Thursday, July 13th. This represents a $2.20 annualized dividend and a dividend yield of 2.41%. Core Laboratories N.V.’s dividend payout ratio is currently 134.15%.

ILLEGAL ACTIVITY WARNING: This story was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this story on another domain, it was illegally copied and republished in violation of US and international copyright and trademark law. The legal version of this story can be accessed at https://www.thecerbatgem.com/2017/09/09/core-laboratories-n-v-clb-stake-lessened-by-mitsubishi-ufj-trust-banking-corp.html.

Core Laboratories N.V. Profile

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.

Want to see what other hedge funds are holding CLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Core Laboratories N.V. (NYSE:CLB).

Institutional Ownership by Quarter for Core Laboratories N.V. (NYSE:CLB)

Receive News & Stock Ratings for Core Laboratories N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories N.V. and related stocks with our FREE daily email newsletter.